# EDGAR Filing Document

**Accession Number:** 0001769759
**File Stem:** 0001104659-25-089487
**Filing Date:** 2025-9
**Character Count:** 6126
**Document Hash:** 4b5f3d80fce7bd9c633d5ac1f0a07a32
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-089487.hdr.sgml**: 20250912

**ACCESSION NUMBER**: 0001104659-25-089487

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 6

**FILED AS OF DATE**: 20250912

**DATE AS OF CHANGE**: 20250912

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Monogram Technologies Inc.
- **CENTRAL INDEX KEY:** 0001769759
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 812349540
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41707
- **FILM NUMBER:** 251311246

**BUSINESS ADDRESS:**
- **STREET 1:** 3913 TODD LANE
- **STREET 2:** SUITE 307
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78744
- **BUSINESS PHONE:** 512-399-2656

**MAIL ADDRESS:**
- **STREET 1:** 3913 TODD LANE
- **STREET 2:** SUITE 307
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78744

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MONOGRAM ORTHOPAEDICS INC
- **DATE OF NAME CHANGE:** 20190305

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14A**

**Proxy Statement Pursuant to Section 14(a) of the**

**Securities Exchange Act of 1934**

**(Amendment No.)**

⌧ Filed by the Registrant ◻ Filed by a Party other than the Registrant

---

| | |
|:---|:---|
| CHECK THE APPROPRIATE BOX: | CHECK THE APPROPRIATE BOX: |
| ◻ | Preliminary Proxy Statement |
| ◻ | Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ◻ | Definitive Proxy Statement |
| ⌧ | Definitive Additional Materials |
| ◻ | Soliciting Material Under §240.14a-12 |

---

**Monogram Technologies Inc.**

**(Name of Registrant as Specified In Its Charter)**

**(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)**

---

| | |
|:---|:---|
| PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): | PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): |
| ⌧ | No fee required |
| ◻ | Fee paid previously with preliminary materials |
| ◻ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

---

On September 12, 2025, the following communication was sent to stockholders of Monogram Technologies Inc.

Dear {{record_holder}},

We'd like to inform you of **two** important items that need your consideration.

&nbsp;&nbsp;&nbsp;&nbsp;1. You still have an opportunity to move
 your shares from us to your brokerage firm should you wish to (i) streamline payment of the
 applicable merger consideration upon consummation of Zimmer Biomet Holdings, Inc.'s
 proposed acquisition of Monogram Technologies Inc. ("Monogram") or (ii) trade
 your shares prior to the consummation. To do so, please log into your account at <u>my.equitystock.com</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· If
 your DRS transfer fee <u>has **not** been paid</u>, and you would like to move your shares
 to your brokerage firm, then you can make the payment directly through our platform at my.equitystock.com.
 There is no requirement to move your shares. If you have any questions regarding your shares,
 please visit <u>our FAQ</u>.

![](tm2525993d2_defa14a-img01.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· If your DRS transfer fee <u>has been paid</u> or is indicated as "Not Applicable", then there
are no payment stops on your shares. You can generate your DRS statement and send it to your brokerage firm, and they will handle the
transfer. You can trade your shares through your brokerage firm should you desire.

To generate your DRS statement:

![](tm2525993d2_defa14a-img02.jpg)

![](tm2525993d2_defa14a-img03.jpg)

**Please note**: Instructions on how to transfer your shares to your broker are posted <u>on our FAQ</u>.

&nbsp;&nbsp;&nbsp;&nbsp;2. Monogram is holding a special meeting
 of shareholders on September 30, 2025, and **your vote matters**. If you have not already
 voted and would like to review the company's proposal and cast your vote, please go
 to <u>www.monogram.vote</u>, click VOTE YOUR PROXY, and enter {{proxy_voting_code}}, which
 is your unique Proxy Voting Code.

![](tm2525993d2_defa14a-img04.jpg)

When you're in the "Proposal" screen, please cast your vote for the two proposals and remember to click **SUBMIT**.

![](tm2525993d2_defa14a-img05.jpg)

If you have already voted, then you can disregard the above and click **<u>Register to attend Monogram Technologies 2025 Special Meeting</u>** to pre-register to attend the special meeting.

**You are reminded that your Board of Directors unanimously recommends that you vote FOR the Merger and related proposals.**

**Monogram urges you to cast your vote TODAY.** Remember, not voting will have the same effect as voting against the Merger. Your vote is important no matter how many shares you own.

Thank you for being a valued shareholder of Monogram Technologies. Should you have any questions regarding your shares or on how to vote, please visit the Monogram FAQ. Should you require any further support, please email: monogram@equitystock.com.

Sincerely,

Shareholder Services

Equity Stock Transfer

<u>www.equitystock.com</u>

***Disclaimer*:**

**Important Information and Where to Find It**

This communication relates to the proposed transaction involving Monogram Technologies Inc. ("Monogram") and Zimmer Biomet Holdings, Inc. In connection with the proposed transaction, Monogram has filed with the Securities and Exchange Commission ("SEC") a proxy statement on Schedule 14A (the "Proxy Statement"). This communication is not a substitute for the Proxy Statement or any other document that Monogram may file with the SEC or send to its stockholders in connection with the proposed transaction. **STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.**